# Tarsus Pharmaceuticals, Inc. (TARS): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Tarsus Pharmaceuticals, Inc. (TARS) is 49/100, ranked against 24,000+ stocks in 35 markets (Quality 56, Value 24, Momentum 62, each scored against its sector).

- StockRank: 49/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 56, Value 24, Momentum 62: each a 0-100 percentile within Healthcare.
- Position: #13,579 overall, #1,227 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 70.03 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors sold USD 7.6M.

Source: https://moatmap.ai/stock/TARS
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker